Ballentine Partners LLC acquired a new stake in shares of Adient (NYSE:ADNT – Free Report) in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 11,526 shares of the company’s stock, valued at approximately $224,000.
A number of other institutional investors have also modified their holdings of ADNT. Brooklyn Investment Group grew its position in shares of Adient by 23,600.0% during the 1st quarter. Brooklyn Investment Group now owns 2,133 shares of the company’s stock valued at $27,000 after buying an additional 2,124 shares during the last quarter. GAMMA Investing LLC lifted its stake in shares of Adient by 157.5% in the 1st quarter. GAMMA Investing LLC now owns 2,235 shares of the company’s stock worth $29,000 after acquiring an additional 1,367 shares during the period. MassMutual Private Wealth & Trust FSB lifted its stake in shares of Adient by 991.0% in the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 2,182 shares of the company’s stock worth $42,000 after acquiring an additional 1,982 shares during the period. Fifth Third Bancorp lifted its stake in shares of Adient by 544.4% in the 2nd quarter. Fifth Third Bancorp now owns 2,133 shares of the company’s stock worth $42,000 after acquiring an additional 1,802 shares during the period. Finally, CWM LLC lifted its stake in shares of Adient by 91.4% in the 1st quarter. CWM LLC now owns 3,426 shares of the company’s stock worth $44,000 after acquiring an additional 1,636 shares during the period. Institutional investors own 92.44% of the company’s stock.
Adient Stock Down 1.5%
ADNT stock opened at $24.26 on Tuesday. Adient has a 52-week low of $10.04 and a 52-week high of $25.84. The company’s 50 day simple moving average is $23.68 and its 200-day simple moving average is $18.56. The company has a debt-to-equity ratio of 1.15, a current ratio of 1.12 and a quick ratio of 0.92. The firm has a market capitalization of $1.97 billion, a P/E ratio of -9.15, a P/E/G ratio of 0.94 and a beta of 1.76.
Wall Street Analysts Forecast Growth
A number of brokerages have recently weighed in on ADNT. Zacks Research lowered shares of Adient from a “strong-buy” rating to a “hold” rating in a research note on Monday, August 18th. Morgan Stanley increased their target price on shares of Adient from $16.00 to $17.00 and gave the company an “underweight” rating in a research note on Tuesday, August 12th. Wall Street Zen raised shares of Adient from a “hold” rating to a “buy” rating in a research note on Friday, July 18th. UBS Group increased their target price on shares of Adient from $25.00 to $26.00 and gave the company a “neutral” rating in a research note on Thursday, August 7th. Finally, Bank of America increased their target price on shares of Adient from $17.50 to $20.00 and gave the company an “underperform” rating in a research note on Wednesday, September 10th. Two research analysts have rated the stock with a Buy rating, six have issued a Hold rating and two have issued a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average price target of $22.63.
View Our Latest Analysis on ADNT
About Adient
Adient plc engages in the design, development, manufacture, and market of seating systems and components for passenger cars, commercial vehicles, and light trucks. The company's automotive seating solutions include complete seating systems, frames, mechanisms, foams, head restraints, armrests, and trim covers.
Recommended Stories
- Five stocks we like better than Adient
- Should You Invest in Penny Stocks?
- Tesla Earnings Loom: Bulls Eye $600, Bears Warn of $300
- Following Congress Stock Trades
- Cathie Wood Buys Alibaba and Baidu: Momentum or More Value Ahead?
- CD Calculator: Certificate of Deposit Calculator
- This ETF Weeds Out Small-Cap Underperformers
Want to see what other hedge funds are holding ADNT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Adient (NYSE:ADNT – Free Report).
Receive News & Ratings for Adient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adient and related companies with MarketBeat.com's FREE daily email newsletter.